Compare CLX & FMS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CLX | FMS |
|---|---|---|
| Founded | 1913 | 1996 |
| Country | United States | Germany |
| Employees | N/A | N/A |
| Industry | Specialty Chemicals | Misc Health and Biotechnology Services |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 12.7B | 13.9B |
| IPO Year | N/A | 1996 |
| Metric | CLX | FMS |
|---|---|---|
| Price | $112.34 | $22.64 |
| Analyst Decision | Hold | Sell |
| Analyst Count | 13 | 2 |
| Target Price | ★ $125.46 | $30.00 |
| AVG Volume (30 Days) | ★ 2.3M | 693.8K |
| Earning Date | 02-03-2026 | 02-24-2026 |
| Dividend Yield | ★ 4.40% | 2.51% |
| EPS Growth | ★ 121.91 | 8.62 |
| EPS | ★ 6.38 | 2.86 |
| Revenue | $6,771,000,000.00 | ★ $23,046,819,198.00 |
| Revenue This Year | N/A | $2.13 |
| Revenue Next Year | $5.60 | $2.95 |
| P/E Ratio | $17.67 | ★ $14.83 |
| Revenue Growth | N/A | ★ 2.10 |
| 52 Week Low | $96.66 | $20.95 |
| 52 Week High | $161.45 | $30.46 |
| Indicator | CLX | FMS |
|---|---|---|
| Relative Strength Index (RSI) | 63.53 | 49.62 |
| Support Level | $108.30 | $22.11 |
| Resistance Level | $113.40 | $22.45 |
| Average True Range (ATR) | 2.44 | 0.45 |
| MACD | 0.17 | 0.09 |
| Stochastic Oscillator | 71.23 | 57.82 |
Since its inception more than 100 years ago, Clorox has expanded to operate in a variety of consumer product categories, including cleaning supplies, laundry care, trash bags, cat litter, charcoal, food dressings, water filtration products, and natural personal care products. Beyond its namesake brand, the firm's portfolio includes Liquid-Plumr, Pine-Sol, S.O.S, Tilex, Kingsford, Fresh Step, Glad, Hidden Valley, KC Masterpiece, Brita, and Burt's Bees. More than 80% of Clorox's sales come from its home turf.
Fresenius Medical Care is the largest dialysis company in the world, treating about 300,000 patients from nearly 3,700 clinics worldwide as of December 2024. In addition to providing dialysis services, the firm is a leading supplier of dialysis products, including machines, dialyzers, and concentrates. Fresenius accounts for about 35% of the global dialysis products market, creating the world's only fully integrated dialysis business. Services account for about three-fourths of sales, while the balance is generated from medical technology products that enable dialysis treatments.